世界のコリン作動薬市場レポート2020年

【英語タイトル】Global Cholinergic Drugs Sales Market Report 2020

QYResearchが出版した調査資料(QYR20JN00261)・商品コード:QYR20JN00261
・発行会社(調査会社):QYResearch
・発行日:2020年6月
・ページ数:138
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥630,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のコリン作動薬市場について種類別(粉末、タブレット、カプセル)、用途別(病院薬局、小売薬局)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・コリン作動薬市場の概要
・世界の主要地域別コリン作動薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のコリン作動薬市場規模2015-2026:種類別(粉末、タブレット、カプセル)
・世界のコリン作動薬市場規模2015-2026:用途別(病院薬局、小売薬局)
・コリン作動薬の北米市場規模2015-2020
・コリン作動薬のヨーロッパ市場規模2015-2020
・コリン作動薬の中国市場規模2015-2020
・コリン作動薬の日本市場規模2015-2020
・コリン作動薬の東南アジア市場規模2015-2020
・コリン作動薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Allergan、Novartis AG、Eisai Co、H Lundbeck A/S、Daiichi Sankyo Company Limited、Ono Pharmaceutical Co Ltd、Johnson & Johnson)
・コリン作動薬の製造コスト分析
・販売チャネル、流通業者、顧客
・コリン作動薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Cholinergic Drugs Market
The global Cholinergic Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Cholinergic Drugs Scope and Market Size
The global Cholinergic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cholinergic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Cholinergic Drugs market is segmented into
Powder
Tablet
Capsule

Segment by Application, the Cholinergic Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
The Cholinergic Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Cholinergic Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cholinergic Drugs Market Share Analysis
Cholinergic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cholinergic Drugs business, the date to enter into the Cholinergic Drugs market, Cholinergic Drugs product introduction, recent developments, etc.
The major vendors covered:
Allergan
Novartis AG
Eisai Co
H Lundbeck A/S
Daiichi Sankyo Company Limited
Ono Pharmaceutical Co Ltd
Johnson & Johnson

【レポートの目次】

Table of Contents

1 Cholinergic Drugs Market Overview
1.1 Cholinergic Drugs Product Scope
1.2 Cholinergic Drugs Segment by Type
1.2.1 Global Cholinergic Drugs Sales by Type (2020-2026)
1.2.2 Powder
1.2.3 Tablet
1.2.4 Capsule
1.3 Cholinergic Drugs Segment by Application
1.3.1 Global Cholinergic Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Cholinergic Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cholinergic Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Cholinergic Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Cholinergic Drugs Price Trends (2015-2026)

2 Cholinergic Drugs Estimate and Forecast by Region
2.1 Global Cholinergic Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cholinergic Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cholinergic Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Cholinergic Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Cholinergic Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cholinergic Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cholinergic Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cholinergic Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Cholinergic Drugs Estimates and Projections (2015-2026)
2.4.3 China Cholinergic Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Cholinergic Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cholinergic Drugs Estimates and Projections (2015-2026)
2.4.6 India Cholinergic Drugs Estimates and Projections (2015-2026)
3 Global Cholinergic Drugs Competition Landscape by Players
3.1 Global Top Cholinergic Drugs Players by Sales (2015-2020)
3.2 Global Top Cholinergic Drugs Players by Revenue (2015-2020)
3.3 Global Cholinergic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholinergic Drugs as of 2019)
3.4 Global Cholinergic Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Cholinergic Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cholinergic Drugs Players (Opinion Leaders)
4 Global Cholinergic Drugs Market Size by Type
4.1 Global Cholinergic Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Cholinergic Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Cholinergic Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Cholinergic Drugs Price by Type (2014-2020)
4.2 Global Cholinergic Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cholinergic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Cholinergic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Cholinergic Drugs Price Forecast by Type (2021-2026)
5 Global Cholinergic Drugs Market Size by Application
5.1 Global Cholinergic Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Cholinergic Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Cholinergic Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Cholinergic Drugs Price by Application (2015-2020)
5.2 Global Cholinergic Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cholinergic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Cholinergic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Cholinergic Drugs Price Forecast by Application (2021-2026)

3 North America Cholinergic Drugs Market Facts & Figures
3.2 North America Cholinergic Drugs Sales Market Share by Company (2015-2020)
3.3 North America Cholinergic Drugs Sales Market Share by Type (2015-2020)
3.4 North America Cholinergic Drugs Sales Market Share by Application (2015-2020)

4 Europe Cholinergic Drugs Market Facts & Figures
4.2 Europe Cholinergic Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Cholinergic Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Cholinergic Drugs Sales Market Share by Application (2015-2020)

5 China Cholinergic Drugs Market Facts & Figures
5.2 China Cholinergic Drugs Sales Market Share by Company (2015-2020)
5.3 China Cholinergic Drugs Sales Market Share by Type (2015-2020)
5.4 China Cholinergic Drugs Sales Market Share by Application (2015-2020)

6 Japan Cholinergic Drugs Market Facts & Figures
6.2 Japan Cholinergic Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Cholinergic Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Cholinergic Drugs Sales Market Share by Application (2015-2020)

7 Southeast Asia Cholinergic Drugs Market Facts & Figures
7.2 Southeast Asia Cholinergic Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Cholinergic Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Cholinergic Drugs Sales Market Share by Application (2015-2020)

8 India Cholinergic Drugs Market Facts & Figures
8.2 India Cholinergic Drugs Sales Market Share by Company (2015-2020)
8.3 India Cholinergic Drugs Sales Market Share by Type (2015-2020)
8.4 India Cholinergic Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Cholinergic Drugs Business
12.1 Allergan
12.1.1 Allergan Cholinergic Drugs Corporation Information
12.1.2 Allergan Cholinergic Drugs Business Overview and Total Revenue
12.1.3 Allergan Cholinergic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Cholinergic Drugs Products Offered
12.1.5 Allergan Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Cholinergic Drugs Corporation Information
12.2.2 Novartis AG Cholinergic Drugs Business Overview and Total Revenue
12.2.3 Novartis AG Cholinergic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis AG Cholinergic Drugs Products Offered
12.2.5 Novartis AG Recent Development
12.3 Eisai Co
12.3.1 Eisai Co Cholinergic Drugs Corporation Information
12.3.2 Eisai Co Cholinergic Drugs Business Overview and Total Revenue
12.3.3 Eisai Co Cholinergic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eisai Co Cholinergic Drugs Products Offered
12.3.5 Eisai Co Recent Development
12.4 H Lundbeck A/S
12.4.1 H Lundbeck A/S Cholinergic Drugs Corporation Information
12.4.2 H Lundbeck A/S Cholinergic Drugs Business Overview and Total Revenue
12.4.3 H Lundbeck A/S Cholinergic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 H Lundbeck A/S Cholinergic Drugs Products Offered
12.4.5 H Lundbeck A/S Recent Development
12.5 Daiichi Sankyo Company Limited
12.5.1 Daiichi Sankyo Company Limited Cholinergic Drugs Corporation Information
12.5.2 Daiichi Sankyo Company Limited Cholinergic Drugs Business Overview and Total Revenue
12.5.3 Daiichi Sankyo Company Limited Cholinergic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Daiichi Sankyo Company Limited Cholinergic Drugs Products Offered
12.5.5 Daiichi Sankyo Company Limited Recent Development
12.6 Ono Pharmaceutical Co Ltd
12.6.1 Ono Pharmaceutical Co Ltd Cholinergic Drugs Corporation Information
12.6.2 Ono Pharmaceutical Co Ltd Cholinergic Drugs Business Overview and Total Revenue
12.6.3 Ono Pharmaceutical Co Ltd Cholinergic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ono Pharmaceutical Co Ltd Cholinergic Drugs Products Offered
12.6.5 Ono Pharmaceutical Co Ltd Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Cholinergic Drugs Corporation Information
12.7.2 Johnson & Johnson Cholinergic Drugs Business Overview and Total Revenue
12.7.3 Johnson & Johnson Cholinergic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Johnson & Johnson Cholinergic Drugs Products Offered
12.7.5 Johnson & Johnson Recent Development

13 Cholinergic Drugs Manufacturing Cost Analysis
13.1 Cholinergic Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cholinergic Drugs
13.4 Cholinergic Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cholinergic Drugs Distributors List
14.3 Cholinergic Drugs Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Cholinergic Drugs Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Cholinergic Drugs Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Cholinergic Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Cholinergic Drugs Sales (K MT) by Region (2015-2020)
Table 5. Global Cholinergic Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Cholinergic Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Cholinergic Drugs Revenue Share by Region (2015-2020)
Table 8. Global Cholinergic Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Cholinergic Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Cholinergic Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Cholinergic Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Cholinergic Drugs (K MT) of Key Companies (2015-2020)
Table 13. Global Cholinergic Drugs Sales Share by Company (2015-2020)
Table 14. Global Cholinergic Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Cholinergic Drugs Revenue Share by Company (2015-2020)
Table 16. Global Cholinergic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholinergic Drugs as of 2019)
Table 17. Global Cholinergic Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Cholinergic Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Cholinergic Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Cholinergic Drugs Players
Table 22. Global Cholinergic Drugs Sales (K MT) by Type (2015-2020)
Table 23. Global Cholinergic Drugs Sales Share by Type (2015-2020)
Table 24. Global Cholinergic Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Cholinergic Drugs Price (K MT) by Type (2015-2020)
Table 26. Global Cholinergic Drugs Sales Share by Type (2021-2026)
Table 27. Global Cholinergic Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Cholinergic Drugs Revenue Share by Type (2021-2026)
Table 29. Global Cholinergic Drugs Price (K MT) by Type (2021-2026)
Table 30. Global Cholinergic Drugs Sales (K MT) by Application (2015-2020)
Table 31. Global Cholinergic Drugs Sales Share by Application (2015-2020)
Table 32. Global Cholinergic Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Cholinergic Drugs Price (K MT) by Application (2015-2020)
Table 34. Global Cholinergic Drugs Sales (K MT) by Application (2021-2026)
Table 35. Global Cholinergic Drugs Sales Share by Application (2021-2026)
Table 36. Global Cholinergic Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Cholinergic Drugs Revenue Share by Application (2021-2026)
Table 38. Global Cholinergic Drugs Price (K MT) by Application (2021-2026)
Table 39. United States Cholinergic Drugs Sales (K MT) by Company (2015-2020)
Table 40. United States Cholinergic Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Cholinergic Drugs Sales (K MT) by Type (2015-2020)
Table 42. United States Cholinergic Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Cholinergic Drugs Sales (K MT) by Application (2015-2020)
Table 44. United States Cholinergic Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Cholinergic Drugs Sales (K MT) by Company (2015-2020)
Table 46. Europe Cholinergic Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Cholinergic Drugs Sales (K MT) by Type (2015-2020)
Table 48. Europe Cholinergic Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Cholinergic Drugs Sales (K MT) by Application (2015-2020)
Table 50. Europe Cholinergic Drugs Sales Market Share by Type (2015-2020)
Table 51. China Cholinergic Drugs Sales (K MT) by Company (2015-2020)
Table 52. China Cholinergic Drugs Sales Market Share by Company (2015-2020)
Table 53. China Cholinergic Drugs Sales (K MT) by Type (2015-2020)
Table 54. China Cholinergic Drugs Sales Market Share by Type (2015-2020)
Table 55. China Cholinergic Drugs Sales (K MT) by Application (2015-2020)
Table 56. China Cholinergic Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Cholinergic Drugs Sales (K MT) by Company (2015-2020)
Table 58. Japan Cholinergic Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Cholinergic Drugs Sales (K MT) by Type (2015-2020)
Table 60. Japan Cholinergic Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Cholinergic Drugs Sales (K MT) by Application (2015-2020)
Table 62. Japan Cholinergic Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Cholinergic Drugs Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Cholinergic Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Cholinergic Drugs Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Cholinergic Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Cholinergic Drugs Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Cholinergic Drugs Sales Market Share by Application (2015-2020)
Table 69. India Cholinergic Drugs Sales (K MT) by Company (2015-2020)
Table 70. India Cholinergic Drugs Sales Market Share by Company (2015-2020)
Table 71. India Cholinergic Drugs Sales (K MT) by Type (2015-2020)
Table 72. India Cholinergic Drugs Sales Market Share by Type (2015-2020)
Table 73. India Cholinergic Drugs Sales (K MT) by Application (2015-2020)
Table 74. India Cholinergic Drugs Sales Market Share by Application (2015-2020)
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Cholinergic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Allergan Cholinergic Drugs Product
Table 79. Allergan Recent Development
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Cholinergic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novartis AG Cholinergic Drugs Product
Table 84. Novartis AG Recent Development
Table 85. Eisai Co Corporation Information
Table 86. Eisai Co Description and Business Overview
Table 87. Eisai Co Cholinergic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Eisai Co Cholinergic Drugs Product
Table 89. Eisai Co Recent Development
Table 90. H Lundbeck A/S Corporation Information
Table 91. H Lundbeck A/S Description and Business Overview
Table 92. H Lundbeck A/S Cholinergic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. H Lundbeck A/S Cholinergic Drugs Product
Table 94. H Lundbeck A/S Recent Development
Table 95. Daiichi Sankyo Company Limited Corporation Information
Table 96. Daiichi Sankyo Company Limited Description and Business Overview
Table 97. Daiichi Sankyo Company Limited Cholinergic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Daiichi Sankyo Company Limited Cholinergic Drugs Product
Table 99. Daiichi Sankyo Company Limited Recent Development
Table 100. Ono Pharmaceutical Co Ltd Corporation Information
Table 101. Ono Pharmaceutical Co Ltd Description and Business Overview
Table 102. Ono Pharmaceutical Co Ltd Cholinergic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Ono Pharmaceutical Co Ltd Cholinergic Drugs Product
Table 104. Ono Pharmaceutical Co Ltd Recent Development
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Cholinergic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Johnson & Johnson Cholinergic Drugs Product
Table 109. Johnson & Johnson Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Cholinergic Drugs Distributors List
Table 113. Cholinergic Drugs Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Cholinergic Drugs Product Picture
Figure 2. Global Cholinergic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cholinergic Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacy Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Global Cholinergic Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Cholinergic Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Cholinergic Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Cholinergic Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Cholinergic Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Cholinergic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Cholinergic Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Cholinergic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Cholinergic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Cholinergic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Cholinergic Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Cholinergic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Cholinergic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Cholinergic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Cholinergic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Cholinergic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Cholinergic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Cholinergic Drugs Players Market Share by Revenue in Cholinergic Drugs 2015 & 2019
Figure 26. Cholinergic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Cholinergic Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Cholinergic Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Cholinergic Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Cholinergic Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Cholinergic Drugs Sales Market Share by Type in 2019
Figure 32. United States Cholinergic Drugs Sales Market Share by Type in 2019
Figure 33. Europe Cholinergic Drugs Sales Market Share by Company in 2019
Figure 34. Europe Cholinergic Drugs Sales Market Share by Type in 2019
Figure 35. Europe Cholinergic Drugs Sales Market Share by Application in 2019
Figure 36. China Cholinergic Drugs Sales Market Share by Company in 2019
Figure 37. China Cholinergic Drugs Sales Market Share by Type in 2019
Figure 38. China Cholinergic Drugs Sales Market Share by Application in 2019
Figure 39. Japan Cholinergic Drugs Sales Market Share by Company in 2019
Figure 40. Japan Cholinergic Drugs Sales Market Share by Type in 2019
Figure 41. Japan Cholinergic Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Cholinergic Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Cholinergic Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Cholinergic Drugs Sales Market Share by Application in 2019
Figure 45. India Cholinergic Drugs Sales Market Share by Company in 2019
Figure 46. India Cholinergic Drugs Sales Market Share by Type in 2019
Figure 47. India Cholinergic Drugs Sales Market Share by Application in 2019
Figure 48. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Eisai Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. H Lundbeck A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Daiichi Sankyo Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Ono Pharmaceutical Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Cholinergic Drugs
Figure 57. Manufacturing Process Analysis of Cholinergic Drugs
Figure 58. Cholinergic Drugs Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed


【掲載企業】

Allergan、Novartis AG、Eisai Co、H Lundbeck A/S、Daiichi Sankyo Company Limited、Ono Pharmaceutical Co Ltd、Johnson & Johnson

【レポートのキーワード】

コリン作動薬、粉末、タブレット、カプセル、病院薬局、小売薬局

★調査レポート[世界のコリン作動薬市場レポート2020年] (コード:QYR20JN00261)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のコリン作動薬市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆